1. Home
  2. ALT vs LE Comparison

ALT vs LE Comparison

Compare ALT & LE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALT
  • LE
  • Stock Information
  • Founded
  • ALT 1997
  • LE 1963
  • Country
  • ALT United States
  • LE United States
  • Employees
  • ALT N/A
  • LE N/A
  • Industry
  • ALT Biotechnology: Pharmaceutical Preparations
  • LE Clothing/Shoe/Accessory Stores
  • Sector
  • ALT Health Care
  • LE Consumer Discretionary
  • Exchange
  • ALT Nasdaq
  • LE Nasdaq
  • Market Cap
  • ALT 457.0M
  • LE 511.4M
  • IPO Year
  • ALT N/A
  • LE N/A
  • Fundamental
  • Price
  • ALT $8.41
  • LE $14.95
  • Analyst Decision
  • ALT Buy
  • LE Strong Buy
  • Analyst Count
  • ALT 7
  • LE 2
  • Target Price
  • ALT $20.00
  • LE $20.00
  • AVG Volume (30 Days)
  • ALT 4.3M
  • LE 115.4K
  • Earning Date
  • ALT 11-12-2024
  • LE 12-03-2024
  • Dividend Yield
  • ALT N/A
  • LE N/A
  • EPS Growth
  • ALT N/A
  • LE N/A
  • EPS
  • ALT N/A
  • LE N/A
  • Revenue
  • ALT $52,000.00
  • LE $1,442,231,000.00
  • Revenue This Year
  • ALT N/A
  • LE N/A
  • Revenue Next Year
  • ALT N/A
  • LE $2.01
  • P/E Ratio
  • ALT N/A
  • LE N/A
  • Revenue Growth
  • ALT N/A
  • LE N/A
  • 52 Week Low
  • ALT $2.50
  • LE $6.35
  • 52 Week High
  • ALT $14.84
  • LE $19.88
  • Technical
  • Relative Strength Index (RSI)
  • ALT 58.51
  • LE 38.20
  • Support Level
  • ALT $6.95
  • LE $14.46
  • Resistance Level
  • ALT $11.16
  • LE $17.29
  • Average True Range (ATR)
  • ALT 0.93
  • LE 0.69
  • MACD
  • ALT 0.02
  • LE -0.18
  • Stochastic Oscillator
  • ALT 41.51
  • LE 15.71

About ALT Altimmune Inc.

Altimmune Inc is engaged in developing treatments for obesity and liver diseases. The Company's pipeline includes next-generation peptide therapeutics for obesity and non-alcoholic steatohepatitis (NASH) (for both, pemvidutide, formerly known as ALT-801), and for chronic hepatitis B (HepTcell). The Company is managed and operates as a single business focused on the research and development of treatments for various diseases and disorders, and vaccines.

About LE Lands' End Inc.

Lands' End Inc is a United States-based multi-channel retailer of casual clothing, accessories, and footwear, as well as home products. The company's operating segment includes U.S. eCommerce; International; Outfitters; Third Party and Retail. It generates maximum revenue from the U.S. eCommerce segment. The U.S. eCommerce segment offers products through the company's eCommerce website. Geographically, it derives a majority of its revenue from the United States.

Share on Social Networks: